Meeting News CoverageVideo

VIDEO: Expert forecasts 2016 hot topics in IBD

ORLANDO — Miguel Regueiro, MD, AGAF, FACG, professor of medicine at University of Pittsburgh, discusses his AIBD presentation on what will be the hot clinical topics in IBD in 2016.

“The talk I gave on the hot topics really revolved around four subject areas,” Regueiro said. “One are biosimilars; [another] is when and if we can stop medications; the third is positioning our current biologic therapies in IBD; and then, finally, these concepts of new models of care in 2016 and beyond, and I touched a little bit upon our patient-centered medical home.”

Disclosures: Regueiro reports he is a consultant for AbbVie, Janssen, Shire, Takeda and UCB.

ORLANDO — Miguel Regueiro, MD, AGAF, FACG, professor of medicine at University of Pittsburgh, discusses his AIBD presentation on what will be the hot clinical topics in IBD in 2016.

“The talk I gave on the hot topics really revolved around four subject areas,” Regueiro said. “One are biosimilars; [another] is when and if we can stop medications; the third is positioning our current biologic therapies in IBD; and then, finally, these concepts of new models of care in 2016 and beyond, and I touched a little bit upon our patient-centered medical home.”

Disclosures: Regueiro reports he is a consultant for AbbVie, Janssen, Shire, Takeda and UCB.

    See more from Advances in IBD